IgG Epitopes Processed and Presented by IgG+ B Cells Induce Suppression by Human Thymic-Derived Regulatory T Cells
暂无分享,去创建一个
J. Sidney | A. Sette | G. Firestein | J. Burns | D. Boyle | A. Franco | Li-En Hsieh | Yoav Altman
[1] W. Frishman,et al. Multisystem Inflammatory Syndrome , 2022, Cardiology in review.
[2] K. Sullivan,et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. , 2020, The Journal of clinical investigation.
[3] Simon Li,et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.
[4] David R. Holtgrave,et al. Multisystem Inflammatory Syndrome in Children in New York State , 2020, The New England journal of medicine.
[5] D. Glass,et al. T regulatory cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells , 2018, Nature Immunology.
[6] B. Becher,et al. T cells in patients with narcolepsy target self-antigens of hypocretin neurons , 2018, Nature.
[7] J. Sidney,et al. Regulatory CD4+ T Cells Recognize Major Histocompatibility Complex Class II Molecule– Restricted Peptide Epitopes of Apolipoprotein B , 2018 .
[8] D. Hafler,et al. Regulatory T cells in autoimmune disease , 2018, Nature Immunology.
[9] D. Neri,et al. Membranal and Blood‐Soluble HLA Class II Peptidome Analyses Using Data‐Dependent and Independent Acquisition , 2018, Proteomics.
[10] Matthew Collin,et al. Human dendritic cell subsets: an update , 2018, Immunology.
[11] Allon M Klein,et al. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR , 2018, Nature Immunology.
[12] Oliver Kohlbacher,et al. HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy , 2017, Oncoimmunology.
[13] J. Ravetch,et al. Fcγ Receptor Function and the Design of Vaccination Strategies. , 2017, Immunity.
[14] Evan W. Newell,et al. Mapping the human DC lineage through the integration of high-dimensional techniques , 2017, Science.
[15] C. Dossier,et al. Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study. , 2017, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.
[16] S. Shen-Orr,et al. Social network architecture of human immune cells unveiled by quantitative proteomics , 2017, Nature Immunology.
[17] N. McGovern,et al. Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment , 2016, Science Immunology.
[18] C. Leslie,et al. Memory of Inflammation in Regulatory T Cells , 2016, Cell.
[19] D. Hafler,et al. Multiple sclerosis: genetics, biomarkers, treatments. , 2016, Current opinion in neurology.
[20] J. Sidney,et al. Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease , 2015, Autoimmunity.
[21] Morten Nielsen,et al. Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires , 2014, Immunogenetics.
[22] J. Kanegaye,et al. Specificity of regulatory T cells that modulate vascular inflammation , 2014, Autoimmunity.
[23] Shimon Sakaguchi,et al. The plasticity and stability of regulatory T cells , 2013, Nature Reviews Immunology.
[24] Clemencia Pinilla,et al. Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture , 2013, Current protocols in immunology.
[25] W. Oertel,et al. Intravenous Immunoglobulins as a Treatment for Alzheimer’s Disease , 2010, Drugs.
[26] J. Cedano,et al. The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles , 2011, Genes and Immunity.
[27] Bjoern Peters,et al. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.
[28] D. Scott,et al. Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". , 2008, Blood.
[29] Cisca Wijmenga,et al. Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis. , 2007, Human molecular genetics.
[30] L. V. D. van de Putte,et al. Role of Fcgamma receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis. , 2003, The Journal of rheumatology.
[31] J. Allison,et al. ICOS co-stimulatory receptor is essential for T-cell activation and function , 2001, Nature.
[32] A Sette,et al. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.
[33] R. de Waal Malefyt,et al. Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. , 1997, Immunity.
[34] A. Lanzavecchia,et al. Processed antigen binds to newly synthesized mhc class II molecules in antigen-specific B lymphocytes , 1991, Cell.
[35] V. Barnaba,et al. Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes , 1990, Nature.
[36] P. Cresswell,et al. Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment , 1990, Nature.
[37] D E Trentham,et al. The immunopathogenesis of rheumatoid arthritis. , 1985, The Journal of rheumatology. Supplement.
[38] Y. Cheng,et al. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.